CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Lifts Price Target on Gilead Sciences to $126 From $123, Keeps Sector Perform Rating

Neutral
AI Analysis

Summary

RBC raised its price target on Gilead Sciences to $126 from $123 while maintaining a Sector Perform rating.

Importance:2/10
Sentiment:
0.20
price_target_raiseequity_researchanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 11:10 AM

Read Original